Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,556,366 papers from all fields of science
Search
Sign In
Create Free Account
Guanarito virus
Known as:
Guanarito arenavirus
, Guanarito mammarenavirus
, Guanarito viruses
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Arenaviridae
Tacaribe Complex Viruses
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection
J. W. Golden
,
B. Beitzel
,
+4 authors
J. Hooper
Scientific Reports
2017
Corpus ID: 256911764
Machupo virus (MACV) is a New World (NW) arenavirus and causative agent of Bolivian hemorrhagic fever (HF). Here, we identified a…
Expand
2013
2013
Mortalidad de vertebrados en la carretera Guanare-Guanarito, estado Portuguesa, Venezuela
A. Seijas
,
Alexis Araujo-Quintero
,
Nadines Velásquez
2013
Corpus ID: 86023081
Vertebrate mortality in the Guanare-Guanarito road, Portuguesa state, Venezuela. Roads directly or indirectly affect the…
Expand
2011
2011
Transmission of Guanarito and Pirital Viruses among Wild Rodents, Venezuela
M. L. Milazzo
,
M. Cajimat
,
G. Duno
,
F. Duno
,
A. Utrera
,
C. F. Fulhorst
Emerging Infectious Diseases
2011
Corpus ID: 6484580
Secretions and excretions from virus-infected cane mice and cotton rats might transmit disease to humans.
Review
2010
Review
2010
ResearchPolyfunctional CD 4 + T cell responses to a set of pathogenic arenaviruses provide broad population coverage
M. Kotturi
,
J. Botten
,
+10 authors
A. Sette
2010
Corpus ID: 1092252
Background: Several arenaviruses cause severe hemorrhagic fever and aseptic meningitis in humans for which no licensed vaccines…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE